Publicaciones en las que colabora con PABLO AVANZAS FERNANDEZ (32)

2024

  1. Concealed Inherited Cardiomyopathies Detected in Cardio-Oncology Screening

    Journal of Clinical Medicine, Vol. 13, Núm. 1

  2. Natural History of Dilated Cardiomyopathy Due to c.77T>C (p.Val26Ala) in Emerin Protein

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  3. PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal

    International Journal of Cardiology, Vol. 413

  4. Prognostic impact of muscle ultrasound-guided diagnosis of sarcopenia in older adults with severe aortic stenosis

    European Geriatric Medicine

  5. Satisfacción del alumnado en la utilización de sus teléfonos móviles como herramienta de gamificación en un entorno universitario

    Aula de encuentro: Revista de investigación y comunicación de experiencias educativas, Vol. 26, Núm. 1, pp. 4-23

  6. Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing

    International Journal of Cardiology, Vol. 408

  7. “Inherited cardiovascular disease mindset” can identify concealed inherited conditions at cardio-oncology evaluation: An opportunistic screening.

    International Journal of Cardiology, Vol. 401

2023

  1. Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  2. Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  3. Functional continuum: independent predictor of one-year mortality and key decision-making element in older adults with severe aortic stenosis amenable to aortic valve replacement

    Aging Clinical and Experimental Research, Vol. 35, Núm. 2, pp. 323-331

  4. Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  5. Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  6. STEMI in women. Life expectancy recovery after primary percutaneous coronary intervention

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1003-1012

2022

  1. Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy

    Life, Vol. 12, Núm. 9

  2. Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR: A Propensity Score Analysis

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 2, pp. 150-161

2021

  1. Frailty assessment in a cohort of elderly patients with severe symptomatic aortic stenosis: Insights from the frailty evaluation in severe aortic stenosis (fresas) registry

    Journal of Clinical Medicine, Vol. 10, Núm. 11

  2. Premature stemi in men and women: Current clinical features and improvements in management and prognosis

    Journal of Clinical Medicine, Vol. 10, Núm. 6

  3. STEMI, primary percutaneous coronary intervention and recovering of life expectancy: insights from the SurviSTEMI study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 829-837

  4. The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 5, pp. 1564-1568

2020

  1. Characterization of left ventricular non-compaction cardiomyopathy

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-16